MIRA Stock Analysis: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$0.91
0.00 (0.04%)
▲
5d:
-3.98%
30d:
-5.2%
90d:
-11.64%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $0.91, which is considered oversold relative to its 30-day fair value range of $0.92 to $0.98.
Technical Outlook: Technically, MIRA is in a strong downtrend. The price is currently testing key support at $0.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MIRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.75 (+1851.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MIRA is in a strong downtrend. The price is currently testing key support at $0.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MIRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.75 (+1851.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.92 -
$0.98
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1851.2% below Wall St target ($17.75)
Trading Range Analysis
30-Day Trading Range
$0.92 -
$0.98
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.96
Resistance Level
$1.20
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.22
Wall Street Target
$17.75
(+1851.2%)
Share & Embed Analysis
Last updated: July 14, 2026 4:54 PM ET
Data refreshes hourly during market hours. Next update: 5:54 PM
Data refreshes hourly during market hours. Next update: 5:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1240 | 56 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 65 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$263 | 58 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$223 | 59 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$356 | 56 HOLD |
